United Therapeutics Corp (UTHR)

137.77 +1.75  +1.29% NASDAQ Nov 23, 20:00 USD
View Full Chart
Price Chart
View All Events

Events

Date Type Description
02/26/2021 Earnings United Therapeutics Corp Fourth Quarter Earnings for 2020 Release
02/26/2021 Misc United Therapeutics Corp Fourth Quarter Earnings Conference Call for 2020
10/28/2020 Earnings United Therapeutics Corp Third Quarter Earnings Result for 2020
10/28/2020 09:00 EDT Misc United Therapeutics Corp Third Quarter Earnings Conference Call for 2020
07/29/2020 09:00 EDT Misc United Therapeutics Corp Second Quarter Earnings Conference Call for 2020
07/29/2020 Earnings United Therapeutics Corp Second Quarter Earnings Result for 2020
06/26/2020 10:15 EDT Misc United Therapeutics Corp Annual General Meeting for 2019
04/29/2020 09:00 EDT Misc United Therapeutics Corp First Quarter Earnings Conference Call for 2020
04/29/2020 Earnings United Therapeutics Corp First Quarter Earnings Result for 2020
02/26/2020 09:00 EST Misc United Therapeutics Corp Fourth Quarter Earnings Conference Call for 2019
View All Performance Charts

Total Returns Comparison

Ratings & Reports

Advertisement
Edit

Profile

  • URL: https://www.unither.com
  • Investor Relations URL: http://ir.unither.com/
  • HQ State/Province: Maryland
  • Sector: Healthcare
  • Industry: Biotechnology
  • Equity Style: Mid Cap/Value
  • Next Earnings Release: Feb. 26, 2021
  • Last Earnings Release: Oct. 28, 2020
  • Next Ex-Dividend Date: N/A
  • Last Ex-Dividend Date: N/A
  • Description: United Therapeutics specializes in drug development for pulmonary arterial hypertension, a rare and progressive disease marked by abnormally high blood pressure in the arteries of the lungs. The company's therapies for pulmonary arterial hypertension largely focus on the prostacyclin pathway, and many of its treatments are based on the same molecule, treprostinil. Nearly all of its sales are generated within the United States. United also markets a pediatric oncology drug, but its focus largely remains in pulmonary hypertension.

Top Fund Holders

Symbol Name Weighting
FBT First Trust NYSE Arca Biotech ETF 4.03%
PJP Invesco Dynamic Pharmaceuticals ETF 3.51%
FXH First Trust Health Care AlphaDEX® ETF 2.52%
FACSX Nuveen Mid Cap Value C 1.96%
FDMLX Fidelity® Series Intrinsic Opps 1.80%
XMLV Invesco S&P MidCap Low Volatility ETF 1.59%
IMPLX ERShares US Large Cap Fund™ Inst 1.52%
XBI SPDR® S&P Biotech ETF 1.13%
MXLSX Great-West Small Cap Value Inv 1.11%
VMFVX Vanguard S&P Mid-Cap 400 Value Idx I 0.81%
IJJ iShares S&P Mid-Cap 400 Value ETF 0.71%
JMEZX JPMorgan Market Expansion Enh Idx R2 0.43%

Comparables

Edit
Advertisement

{{root.upsell.info.feature_headline}}.

{{root.upsell.info.feature_description}}

Please note that this feature is only available as an add-on to YCharts subscriptions.


Please note that this feature requires full activation of your account and is not permitted during the free trial period.

Start My Free Trial {{root.upsell.info.call_to_action}} No credit card required.

Already a subscriber? Sign in.